HIV and Vaccination: Guidelines, Safety, and Recommended Vaccines

People living with HIV (PLWH) can and should receive most routine vaccines. Vaccination is a critical component of preventive care because HIV increases susceptibility to certain infections and their complications.

General Principles

  • Inactivated/killed vaccines are safe at any CD4 count.
  • Live attenuated vaccines (MMR, varicella, yellow fever, intranasal influenza, oral typhoid) are generally contraindicated if CD4 < 200 cells/µL or if the patient is severely immunocompromised. They may be considered if CD4 ≥ 200 and viral load is suppressed.
  • Vaccine response may be blunted with low CD4 counts; revaccination after immune reconstitution (on ART) is often recommended.

Routinely Recommended Vaccines for Adults with HIV

VaccineSchedule / Notes
Hepatitis B3-dose series (0, 1, 6 mo); check anti-HBs titer post-vaccination; revaccinate if non-responder
Hepatitis A2-dose series; recommended for all PLWH
MMR (Measles, Mumps, Rubella)Live vaccine; give if CD4 ≥ 200; 2 doses if no evidence of immunity
Varicella (Chickenpox)Live vaccine; give if CD4 ≥ 200; 2 doses if no immunity
Tdap / TdTdap once, then Td/Tdap booster every 10 years
Influenza (inactivated)Annual; avoid live intranasal (LAIV)
PneumococcalPCV20 alone, or PCV15 followed by PPSV23 ≥1 year later
HPV (Human Papillomavirus)3-dose series through age 26; shared decision-making for 27–45
COVID-19Updated mRNA/protein vaccines per current CDC guidance; additional doses if immunocompromised
Herpes Zoster (Shingles)Recombinant zoster vaccine (RZV/Shingrix) 2 doses – preferred (non-live); safe at any CD4
Meningococcal (MenACWY, MenB)Based on risk factors (asplenia, travel, outbreaks)

Special Considerations

  • Timing: Vaccinate early after HIV diagnosis, ideally after ART initiation and CD4 recovery.
  • Monitoring: Check antibody titers for Hep B; consider pneumococcal titer if high risk.
  • Travel Vaccines: Yellow fever (live) requires CD4 ≥ 200 and careful risk-benefit assessment; oral typhoid (live) avoided if CD4 < 200.

Consultation

Decisions should be made with an HIV specialist or infectious disease provider who can assess immune status, ART adherence, and individual risk factors.

HIV & AIDS - Related Articles